Eisai Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

About Eisai Contact Number

Or call us at your product’s phone number, below: ACIPHEX ® (rabeprazole sodium) delayed release tablets: 1-800-769-3880 ARICEPT ® (donepezil hydrochloride) tablets: 1-800-769-3880

Contact US: https://us.eisai.com/contact-us

How to contact Eisai Australia and New Zealand?

For any medical information enquiries or to report an adverse event, please phone Eisai Australia & New Zealand medical information on +61 (0) 3 9832 9100, send email to [email protected] or contact your treating health professional. Thank you for your interest in Eisai.

What is the phone number for Eisai Medical?

Please contact Eisai Medical Information for any questions about our products at 888-274-2378 (8:30 AM - 5:00 PM, Eastern Time, Monday - Friday).

Who is the parent company of Eisai Inc?

Eisai Inc. (pronounced ā-zī) is a U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd, a research-based human health care (hhc) company that discovers, develops and markets products throughout the world.

What is the role of Eisai in India?

Eisai Pharmaceuticals India Pvt. Ltd (EIL) represents one of Eisai’s integrated Manufacturing and Research complexes fulfilling the company’s long held ambition to bring teams from across its business together on one site for the first time i.e. manufacturing of Drug Substances (Active Pharmaceutical Ingredients-APIs),

Office

42 People Used

See More ››

Contact Us Eisai Co., Ltd.

Contact Us. Thank you for your interest in Eisai. In order for us to respond to all customer inquiries as quickly and helpfully as possible, please direct your inquiry to the appropriate office for your country or region. (For global-related issues, please contact our global head office in Tokyo, Japan.)

View Contact ››

Contact

51 People Used

See More ››

Worldwide Contact Information Contact Us Eisai Co., Ltd.

Alternatively, please call the number below during the following business hours: Monday to Friday, 9 a.m. to 5 p.m. (JST). Contact Form (global head office) Main Switchboard: 81-3-3817-3700. Contact Us.

View Contact ››

Eisai

36 People Used

See More ››

Eisai Co., Ltd.

eisai and bristol myers squibb enter into global strategic collaboration for eisai’s morab-202 antibody drug conjugate. june 15, 2021. eisai to divest rights for zonegran® in europe and other regions to advanz pharma. june 9, 2021. eisai receives special prize at platinum career award 2021. june 9, …

View Contact ››

Eisai

26 People Used

See More ››

Eisai Inc., A U.S. Research-based Healthcare Company

Eisai Inc. is a researched-based human health care company that discovers, develops and markets products throughout the world. Learn more about Eisai today.

View Contact ››

Patient

120 People Used

See More ››

Phone: 1-866-61-EISAI (1-866-613-4724) • Fax: 1-855-246-5192

Phone: 1-866-61-EISAI (1-866-613-4724) • Fax: 1-855-246-5192 Physician Information Patient Information Patient Name Date of Birth Gender SSN Street Address City State Zip Patient Phone Number Cell Phone Number Email Primary Language Alternate Contact Name Relationship to Patient Alternate Contact Telephone Allergies Current Medications

View Contact ››

Countries

62 People Used

See More ››

Eisai Co., Ltd.

28 countries 2.02 billion tablets. Number of countries supplied with lymphatic filariasis treatment and volume supplied (as of May 2021) Eisai is promoting initiatives for improving access to medicines to contribute to people in developing and emerging countries

View Contact ››

Corporate

59 People Used

See More ››

Eisai Sci Comms Contacts

EISAI ONCOLOGY [ CONTACT INFORMATION ] CORPORATE AFFAIRS. Joel Beetsch Vice President, Corporate Affairs. [email protected]eisai.com. Teresa Cronin Senior Director, Corporate Advocacy. [email protected]eisai.com. KEY ACCOUNT MANAGERS. David Lance Associate Director, ICAM. [email protected]eisai.com.

View Contact ››

Medical

45 People Used

See More ››

Contact Us

Medical and Safety information: For any medical information enquiries or to report an adverse event, please phone Eisai Australia & New Zealand medical information on +61 (0) 3 9832 9100, send email to [email protected]eisai.net or contact your treating health professional. Thank you for your interest in Eisai.

View Contact ››

Click

42 People Used

See More ››

Contact Us Eisai Europe

For media enquiries please click here.. To report an adverse event or side effect click here and select if you are a healthcare professional or a patient.. If you are a healthcare professional and you have a medical information enquiry click here.. If you are a patient and need to contact the Medical Information department, please complete the form on this page.

View Contact ››

Corporate

62 People Used

See More ››

Eisai Neurology Contacts

EISAI NEUROLOGY [ CONTACT INFORMATION ] CORPORATE AFFAIRS. Joel Beetsch Vice President, Corporate Affairs (201) 746-2080. [email protected]eisai.com. Teresa Cronin Senior Director, Corporate Advocacy (201) 949-4326. [email protected]eisai.com. NEUROLOGY SALES LEADERS. Kristy Como Executive Director, Epilepsy.

View Contact ››

Pharmaceutical

76 People Used

See More ››

Hi-Eisai Pharmaceutical In Makati City, Metro Manila

Find contact information, products, services, photos, videos, branches, events, promos, jobs and maps for Hi-Eisai Pharmaceutical in 20/F, Multinational Bancorporation Center, 6805 Ayala Avenue, Makati City, Metro Manila

View Contact ››

Eisai

43 People Used

See More ››

Eisai

Eisai Global Headquarters Eisai Co., Ltd. Public Relations Department 4-6-10 Koishikawa, Bunkyo-ku, Tokyo 112-8088, Japan 81-3-3817-5120

View Contact ››

E-mail

53 People Used

See More ››

Contact Us

If you wish to contact us please use the details below. Switzerland address: Eisai Pharma AG. Leutschenbachstrasse 95. 8050 Zürich. Phone: 044 306 12 12. Fax: 044 306 12 80. e-mail: [email protected]eisai.net.

View Contact ››

China

69 People Used

See More ››

Eisai Group Worldwide Corporate Information Eisai Co

Eisai China Holdings Ltd. (China) 32 Bai Yu Road, Suzhou Industrial Park, Jiangsu Province, 215021 China Tel: 86-512-6761-3211 Fax: 86-512-6761-8640

View Contact ››

Eisai

123 People Used

See More ››

Website Of Eisai Pharmatechnology And Manufacturing Pvt

Eisai Pharmatechnology and Manufacturing Pvt Ltd with all necessary information like Reviews, Rating, contact number, address, phone number, email, website, description and all business information of Eisai Pharmatechnology and Manufacturing Pvt Ltd Visakhapatnam 392847

View Contact ››

Clinical

48 People Used

See More ››

Who We Are Eisai Inc.

learn more about Eisai’s compound under clinical trials 17 patient Programs. The number of Eisai U.S. compounds currently in clinical development (Phase 2 or later) and being evaluated for 30 indications

View Contact ››

Eisai

40 People Used

See More ››

Eisai Company Profile

Eisai increases the number of participants in Clarity AD study STOCKHOLM, Feb. 3, 2021 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that they have increased the participant target number by approximately 200 in the pivotal Phase 3 study, Clarity AD, of drug candidate lecanemab (BAN2401) for the

View Contact ››

Eisai

56 People Used

See More ››

Have Questions

Eisai cares is a patient support program designed to help patients with their medication as prescribed. To learn more about Eisai Cares or to speak to a Nurse Case Manager: Call us at 1-844-980-0410. Monday to Friday, 8am to 8pm (EST) [email protected]

View Contact ››

Please leave your comments here:

Popular Brands

Eqt
Edf
Enel
Evergy
Eaton
Emera
Eisai
Eni